NeedleSmart Overview
- Year Founded
-
2015
- Status
-
Acquired/Merged
- Employees
-
12
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$4.2M
NeedleSmart General Information
Description
Developer of clinical workflow automation technology designed for injections and vaccinations. The company's platform streamlines the end-to-end process, reducing appointment time while improving data management, enabling businesses to increase safety, clinical decision-making support, and environmental impact.
Contact Information
Website
www.needlesmart.com(Operating Subsidiary)
Corporate Office
- 2400 Market Street
- Suite 200
- Philadelphia, PA 19103
- United States
Corporate Office
- 2400 Market Street
- Suite 200
- Philadelphia, PA 19103
- United States
NeedleSmart Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC | 23-Oct-2023 | $4.2M | Completed | Generating Revenue | ||
| 4. Merger/Acquisition | 01-Jan-2022 | Completed | Startup | |||
| 3. Early Stage VC | 06-Jan-2019 | Completed | Startup | |||
| 2. Angel (individual) | $11.7M | $11.7M | Completed | Startup | ||
| 1. Angel (individual) | 20-Dec-2016 | Completed | Startup |
NeedleSmart Comparisons
Industry
Financing
Details
NeedleSmart Competitors (3)
One of NeedleSmart’s 3 competitors is Vaxxas, a Venture Capital-Backed company based in Hamilton, Australia.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Vaxxas | Venture Capital-Backed | Hamilton, Australia | ||||
| NanoPass Technologies | Venture Capital-Backed | Nes Ziona, Israel | ||||
| PharmaJet | Venture Capital-Backed | Golden, CO |
NeedleSmart Patents
NeedleSmart Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240366886-A1 | Hypodermic needle destruction | Pending | 09-Jul-2021 | ||
| WO-2023281234-A1 | Hypodermic needle destruction | Inactive | 09-Jul-2021 | ||
| GB-202010450-D0 | Hypodermic needle destruction | Inactive | 07-Jul-2020 | ||
| CA-3103591-A1 | Phlebotomy needle destruction | Pending | 12-Jun-2018 | ||
| EP-3806936-A1 | Phlebotomy needle destruction | Active | 12-Jun-2018 | A61M5/3278 |
NeedleSmart Signals
NeedleSmart Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| McKenny-McFarlane Capital | PE/Buyout | Minority |
NeedleSmart FAQs
-
When was NeedleSmart founded?
NeedleSmart was founded in 2015.
-
Where is NeedleSmart headquartered?
NeedleSmart is headquartered in Philadelphia, PA.
-
What is the size of NeedleSmart?
NeedleSmart has 12 total employees.
-
What industry is NeedleSmart in?
NeedleSmart’s primary industry is Other Devices and Supplies.
-
Is NeedleSmart a private or public company?
NeedleSmart is a Private company.
-
What is the current valuation of NeedleSmart?
The current valuation of NeedleSmart is .
-
What is NeedleSmart’s current revenue?
The current revenue for NeedleSmart is .
-
How much funding has NeedleSmart raised over time?
NeedleSmart has raised $4.2M.
-
Who are NeedleSmart’s investors?
McKenny-McFarlane Capital has invested in NeedleSmart.
-
Who are NeedleSmart’s competitors?
Vaxxas, NanoPass Technologies, and PharmaJet are competitors of NeedleSmart.
-
When was NeedleSmart acquired?
NeedleSmart was acquired on 23-Oct-2023.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process